Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Ravaud

Showing results (371-380 of 457) with videos related to

Pageof 46
Sort By:
Arthritis Care & Research|October 10, 2014
Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registrySarah Payet, Martin Soubrier, Elodie Perrodeau, et al.
Joint Bone Spine|November 27, 2007
Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritisBruno Fautrel, Thao Pham, Gaël Mouterde, et al.
Rheumatology (Oxford, England)|January 30, 2016
Effectiveness and safety of abatacept in elderly patients with rheumatoid arthritis enrolled in the French Society of Rheumatology's ORA registryClément Lahaye, Martin Soubrier, Aurélien Mulliez, et al.
Rheumatology (Oxford, England)|May 14, 2014
Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registryMarion Couderc, Jacques-Eric Gottenberg, Xavier Mariette, et al.
Anesthesiology|March 11, 2010
Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary studyCatherine Paugam-Burtz, Miguel Albuquerque, Gabriel Baron, et al.
European Heart Journal|February 26, 2010
Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosisGregory Ducrocq, Joshua S Wallace, Gabriel Baron, et al.
Contemporary Clinical Trials|October 19, 2010
Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies--the Pre-Optimon studyValérie Journot, Jean-Pierre Pignon, Claude Gaultier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2005
High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-AutogreffeJean-Paul Fermand, Sandrine Katsahian, Marine Divine, et al.
BMJ Open|May 7, 2015
Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meetingJoerg J Meerpohl, Lisa K Schell, Dirk Bassler, et al.
BMJ (Clinical Research Ed.)|January 26, 2019
Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort studyJacques-Eric Gottenberg, Jacques Morel, Elodie Perrodeau, et al.
Pageof 46

Showing results (371-380 of 457) with videos related to

Sort By:
Pageof 46
Arthritis Care & Research|October 10, 2014
Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registrySarah Payet, Martin Soubrier, Elodie Perrodeau, et al.
Joint Bone Spine|November 27, 2007
Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritisBruno Fautrel, Thao Pham, Gaël Mouterde, et al.
Rheumatology (Oxford, England)|January 30, 2016
Effectiveness and safety of abatacept in elderly patients with rheumatoid arthritis enrolled in the French Society of Rheumatology's ORA registryClément Lahaye, Martin Soubrier, Aurélien Mulliez, et al.
Rheumatology (Oxford, England)|May 14, 2014
Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registryMarion Couderc, Jacques-Eric Gottenberg, Xavier Mariette, et al.
Anesthesiology|March 11, 2010
Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary studyCatherine Paugam-Burtz, Miguel Albuquerque, Gabriel Baron, et al.
European Heart Journal|February 26, 2010
Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosisGregory Ducrocq, Joshua S Wallace, Gabriel Baron, et al.
Contemporary Clinical Trials|October 19, 2010
Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies--the Pre-Optimon studyValérie Journot, Jean-Pierre Pignon, Claude Gaultier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2005
High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-AutogreffeJean-Paul Fermand, Sandrine Katsahian, Marine Divine, et al.
BMJ Open|May 7, 2015
Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meetingJoerg J Meerpohl, Lisa K Schell, Dirk Bassler, et al.
BMJ (Clinical Research Ed.)|January 26, 2019
Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort studyJacques-Eric Gottenberg, Jacques Morel, Elodie Perrodeau, et al.
Pageof 46